Literature DB >> 6995334

Role of Kupffer cells, complement, and specific antibody in the bactericidal activities of perfused livers.

R L Friedman, R J Moon.   

Abstract

The relative roles of Kupffer cells, complement, and specific antibody in liver antimicrobial activities were investigated by using a rat liver perfusion model. Normal livers trapped an average of 60% of Salmonella typhimurium in a single pass and in the presence of plasma killed more than 60% of these organisms in 30 min. Livers depleted of Kupffer cell function by silica treatment had significantly less bactericidal ability (ca. 15%) in the presence of plasma, showing that viable Kupffer cells are required for optimal antimicrobial activity. To determine the importance of complement in Salmonella killing, plasma complement activity was inhibited by heating at 57 and 50 degrees C, zymosan absorption, chelation with disodium ethylenediaminetetraacetate (EDTA) and depletion of rat C3 by using specific immunoabsorbent. All treatments significantly reduced bactericidal activity in the perfused liver. Chelation of plasma with EDTA had no effect, suggesting that the alternate and not the classical pathway for complement activation was involved. Immune plasma alone was bactericidal. When immune plasma was heated, zymosan absorbed, or chelated with EDTA, bactericidal activity was inhibited in the perfused liver, but bacterial trapping increased. These results suggest that complement is required for bactericidal activity in perfused livers and that specific antibody only enhances bacterial trapping.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6995334      PMCID: PMC551088          DOI: 10.1128/iai.29.1.152-157.1980

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  23 in total

1.  Functional relationship of factor B in the properdin system to C3 proactivator of human serum.

Authors:  I Goodkofsky; I H Lepow
Journal:  J Immunol       Date:  1971-10       Impact factor: 5.422

2.  The stoichiometric measurement of the serum inhibition of the first component of complement by the inhibition of immune hemolysis.

Authors:  I Gigli; S Ruddy; K F Austen
Journal:  J Immunol       Date:  1968-06       Impact factor: 5.422

3.  The IgG receptor: an immunological marker for the characterization of mononuclear cells.

Authors:  H Huber; S D Douglas; H H Fudenberg
Journal:  Immunology       Date:  1969-07       Impact factor: 7.397

4.  Interaction of complex polysaccharides with the complement system: effect of calcium depletion on terminal component consumption.

Authors:  R Snyderman; M C Pike
Journal:  Infect Immun       Date:  1975-02       Impact factor: 3.441

5.  Role of antibody and complement in the immune clearance and destruction of erythrocytes. II. Molecular nature of IgG and IgM complement-fixing sites and effects of their interaction with serum.

Authors:  A D Schreiber; M M Frank
Journal:  J Clin Invest       Date:  1972-03       Impact factor: 14.808

6.  C3 shunt activation in human serum chelated with EGTA.

Authors:  D P Fine; S R Marney; D G Colley; J S Sergent; R M Des Prez
Journal:  J Immunol       Date:  1972-10       Impact factor: 5.422

7.  Receptors for immunoglobulin and complement on human alveolar macrophages.

Authors:  H Y Reynolds; J P Atkinson; H H Newball; M M Frank
Journal:  J Immunol       Date:  1975-06       Impact factor: 5.422

8.  Mass isolation and culture of rat kupffer cells.

Authors:  A C Munthe-Kaas; T Berg; P O Seglen; R Seljelid
Journal:  J Exp Med       Date:  1975-01-01       Impact factor: 14.307

9.  Phagocytosis of immune complexes by macrophages. Different roles of the macrophage receptor sites for complement (C3) and for immunoglobulin (IgG).

Authors:  B Mantovani; M Rabinovitch; V Nussenzweig
Journal:  J Exp Med       Date:  1972-04-01       Impact factor: 14.307

10.  An examination of the cytotoxic effects of silica on macrophages.

Authors:  A C Allison; J S Harington; M Birbeck
Journal:  J Exp Med       Date:  1966-08-01       Impact factor: 14.307

View more
  6 in total

1.  Arg-Gly-Asp (RGD) peptides alter hepatic killing of Candida albicans in the isolated perfused mouse liver model.

Authors:  R T Sawyer; R E Garner; J A Hudson
Journal:  Infect Immun       Date:  1992-01       Impact factor: 3.441

2.  Trapping and killing of Candida albicans by Corynebacterium parvum-activated livers.

Authors:  R T Sawyer; R J Moon; E S Beneke
Journal:  Infect Immun       Date:  1981-05       Impact factor: 3.441

3.  The liver as a major site of immunological elimination of murine trypanosome infection, demonstrated with the liver perfusion model.

Authors:  J W Albright; G W Long; J F Albright
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

4.  Lysosomal enzyme content of Kupffer and endothelial liver cells isolated from germfree and clean conventional rats.

Authors:  D L Knook; C Barkway; E C Sleyster
Journal:  Infect Immun       Date:  1981-08       Impact factor: 3.441

5.  Opsonic requirements for hepatic clearance of pneumococci.

Authors:  W P Reed; E L Albright
Journal:  Infect Immun       Date:  1986-05       Impact factor: 3.441

6.  Effects of zinc oxide nanoparticles on Kupffer cell phagosomal motility, bacterial clearance, and liver function.

Authors:  Christa Y Watson; Ramon M Molina; Andressa Louzada; Kimberly M Murdaugh; Thomas C Donaghey; Joseph D Brain
Journal:  Int J Nanomedicine       Date:  2015-06-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.